Reference

Silicone-based topical wound healing promoting preparations used together with negatively-chargeable sheets

Silicone-based topical wound healing promoting preparations used together with negatively-chargeable sheets. Harasawa, Masazumi; Soneda, Hiroshi (Harasawa Pharmaceutical Co., Ltd., Japan). Jpn. Kokai Tokkyo Koho JP 2005029526 A2 3 Feb 2005, 9 pp. (Japanese). (Japan). CODEN: JKXXAF. CLASS: ICM: A61K007-48. ICS: A61K007-00; A61K007-42. APPLICATION: JP 2003-272230 9 Jul 2003. DOCUMENT TYPE: Patent CA Section: 62 (Essential Oils and Cosmetics) Section cross-reference(s): 1, 63 The prepns. comprise silicone-based skin prepns. and cover sheets which are electrostatically chargeable at neg. potential. The skin prepns. may addnl. contain skin-lightening agents, UV-shielding agents, chitosan, and substances which promote neg. electrostatic potential generation.In this experiment, several chemicals are used like 9012-76-4 and 84380-01-8 Thus, a silicone sheet was coated with a gel contg. 98% KSG 210 (silicone) and 2% a-arbutin and applied to acne spots of a female volunteers overnight. The acne spots were significantly reduced after 3 mo. .

Method and topical composition comprising vismia and phytic acid for the treatment of hyperpigmented skin

Method and topical composition comprising vismia and phytic acid for the treatment of hyperpigmented skin. Rendon, Marta I. (USA ). U.S. Pat. Appl. Publ. US 2005019282 A1 27 Jan 2005,15 pp. (English). (United States of America).Some commonly used reagents like 84380-01-8 and 1406-18-4 are used in this experiment. CODEN: USXXCO. CLASS: ICM: A61K007-135. NCL: 424062000. APPLICATION: US 2003-624227 22 Jul 2003. DOCUMENT TYPE: Patent CA Section: 62 (Essential Oils and Cosmetics) Section cross-reference(s): 63 The present invention relates to novel, topically applied, cosmetic/dermatol. compns. comprising a mixt. of Vismia and phytic acid for the treatment of hyperpigmentation disorders and photodamaged human skin. The subject compns. combat hyperpigmented skin. In addn., the compds. described can be used in the treatment of many other pathologies. Due to a high degree of gentleness, along with potent antioxidant and moisturizing effects, the present invention can be used safely in the treatment of many conditions, such as the prevention and/or treatment of melasma, freckles, age spots (lentigo senilis) and photodamaged skin. For example, a skin brightener formulation contained a-arbutin 1%, ascorbic acid 1%, cetearyl alc. 3%, citric acid 2%, fragrance 0.2%, green tea ext. 1%, water 63%, iso-Pr palmitate 5%, inositol hexanicotinate 4%, kojic acid dipalmitate 2%, menthyl lactate 1%, arachidyl alc., behenyl alc. and arachidyl glucoside 0.3%, preservative 5%, hyaluronic acid/sodium lactate 0.3%, propylene glycol 3%, Rumex crispus ext. 3%, polyacrylamide/C13-14 isoparaffin/laureth-7 3%, Vismia ext. 2%, and vitamin E 0.2%. .